Altruist Biologics is a fully integrated CDMO, focusing on the development and commercial manufacturing of antibodies, fusion proteins, ADCs, and other drugs. From cell line development to aseptic fill/finish, we are committed to supporting our clients develop affordable and high-quality biopharmaceuticals for the benefit of patients worldwide. We offer a total 60KL capacity at our Suzhou site, and commenced partial operations at our new Hangzhou facility with the completion of four 20KL bioreactors, the first and largest of its kind in China. The site will hold a total capacity of 172KL when it becomes fully completed in the second half of 2024. Guided by the values of “Perseverance for Altruism, Ingenuity for Sustainability,” we continuously strengthen our capabilities and quality systems in line with anticipated market and client needs to provide the most efficient and cost-effective services.